J&J consolidation splits Rx brands between two holding companies
Johnson & Johnson has consolidated the $150 million US advertising business for its prescription drugs, worth around $110 million in agency fees, into WPP and Interpublic Group, with WPP winning its CNS, oncology and anti-infectives brands and IPG landing the pain, women's health, GI and HIV franchises.
The e-mail address(es) that you supply to use this service will only be used to send the requested article.